Q32 Bio Stock Forecast

Stock Price Forecast

According to 6 analysts polled by S&P Global, Q32 Bio stock has a consensus rating of "Strong Buy" and an average price target of $41. The average 1-year stock price forecast is 241.95% higher than the current stock price, while the lowest is $34 (+183.57%) and the highest is $59 (+392.08%).

Price Target: $41 (+241.95%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$34	$41	$36	$59
Change	+183.57%	+241.95%	+200.25%	+392.08%

Analyst Ratings

The average analyst rating for Q32 Bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	Feb '26	Mar '26	Apr '26	May '26	Jul '26	Aug '26
Strong Buy	2	2	2	4	5	5
Buy	0	0	0	0	0	1
Hold	1	1	1	1	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	5	5	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Judah Frommer Morgan Stanley	Morgan Stanley	Buy Initiates $34	Buy	Initiates	$34	+183.57%	Aug 24, 2026
Jay Olson Oppenheimer	Oppenheimer	Buy Maintains $40	Buy	Maintains	$40	+233.61%	Aug 6, 2026
Derek Archila Wells Fargo	Wells Fargo	Buy Reiterates $66 → $59	Buy	Reiterates	$66 → $59	+392.08%	Aug 6, 2026
Joseph Pantginis H.C. Wainwright	H.C. Wainwright	Buy Reiterates $36	Buy	Reiterates	$36	+200.25%	Aug 5, 2026
Joseph Catanzaro Mizuho Securities	Mizuho Securities	Buy Reiterates $14 → $36	Buy	Reiterates	$14 → $36	+200.25%	Jul 13, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

400.00K

from 53.74M

-99.26%

from 53.74M

Revenue Next Year

1.00M

from 400.00K

150.00%

from 400.00K

EPS This Year

-1.13

from -

EPS Next Year

-1.02

from -1.13

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	6.65M	-6.65M	-	53.74M	400.00K
Revenue Growth	-	-	-	-	-	-99.26%
Operating Income	-36.69M	-39.23M	-48.26M	-66.10M	16.90M	-37.12M
Net Income	-37.56M	-42.81M	-53.74M	-47.73M	29.82M	-34.29M
EPS	-	-	-	-	-	-1.13
Free Cash Flow	-	-8.73M	-41.84M	-37.95M	4.52M	-34.00M
No. Analysts	-	-	-	-	-	5

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	2.0M
Avg	400,000
Low	n/a

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	-96.3%
Avg	-99.3%
Low	-100.0%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-1.13
Avg	-1.13
Low	-1.13

EPS Growth

Chart

EPS Growth	2027	2028
High	-
Avg	-
Low	-